Most women treated in New York City for gynecologic cancers are not at increased risk of death from COVID-19

covid
Credit: Unsplash/CC0 Public Domain

Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows. The researchers found that neither having cancer nor receiving treatment for it, which can come with its own toxicities, worsened COVID-19 disease outcomes.

Led by researchers at NYU Langone's Perlmutter Cancer Center and NYU Grossman School of Medicine, the study showed that 121 , ages 51 to 63, who were receiving standard treatments for such malignancies and who contracted the pandemic coronavirus had similar rates of hospitalization and death as those who only had COVID-19.

Publishing in the journal Cancer online July 31, the study showed that 54 percent of the women (66 of 121) required hospitalization and among these, 25 percent (17 of 66) died, for an overall death rate of 14 percent. This is comparable to the results of another study, which showed a 21 percent death rate among all 5,700 hospitalized patients with COVID-19 in the city, who were mostly male (60 percent) and at greater risk of the disease, researchers say.

Having late-stage gynecologic cancer, cancer surgery, or high-dose chemotherapy also did not increase a woman's risk of dying from COVID-19.

Importantly, the work also found that 75 percent of gynecologic cancer patients with COVID-19 had a mild form of the disease and recovered from their infection.

"Our study should be reassuring for women with gynecologic cancers who are worried that having cancer increases their risk of becoming seriously ill if they go to the hospital because of COVID-19," says study lead investigator Olivia Lara, MD, an oncology fellow in the Department of Obstetrics and Gynecology at Perlmutter. These patients already contend with increased inflammation and imbalanced immune systems that, in theory, coronavirus infection could make worse.

"Women with gynecologic cancers have the same risk factors for dying from COVID-19 as women without these cancers," says study senior investigator Bhavana Pothuri, MD, MS, a professor in the Department of Obstetrics and Gynecology at Perlmutter.

These shared risk factors, she says, which overall double women's risk of dying from COVID-19, are being African-American or having two or more underlying health conditions, such as hypertension, obesity, and diabetes.

As part of the study, researchers reviewed the medical records of women treated for both COVID-19 and gynecologic cancer at area hospitals between March 1 and April 22, 2020. These included NYU Langone's Perlmutter Cancer Center, NYC Health + Hospitals Bellevue Hospital, Memorial Sloan-Kettering Cancer Center, Columbia University Medical Center, SUNY Downstate Medical Center, and the Montefiore Medical System.

Another study finding was that a small number (eight of 121) of participants receiving immunotherapy, drugs that harness the to attack cancer cells, were three times more likely to die than women who were receiving standard radiation, surgery, chemotherapy, or a combination of these therapies. However, Pothuri cautions that the number of women receiving immunotherapy was not large enough to lead to any firm recommendations about clinical care. (or to result in any firm conclusions about )

Pothuri says the team has plans to analyze patient records for further insights into any factors that might lessen the impact of these underlying for COVID-19 on women with cancer, including how best to communicate with local community groups.

For now, Pothuri says, women should definitely not put off screening, diagnosis, or treatment of new cancers out of any additional fear they have about the risks from COVID-19. "The basic rules of care have not changed during the pandemic," she says. "Early detection, screening, and care lead to more people surviving what remains a leading cause of death among American women."


Explore further

Researchers find that common cancer treatments don't worsen coronavirus infection

Journal information: Cancer

Provided by NYU Langone Health
Citation: Most women treated in New York City for gynecologic cancers are not at increased risk of death from COVID-19 (2020, July 30) retrieved 12 August 2020 from https://medicalxpress.com/news/2020-07-women-york-city-gynecologic-cancers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments